Ö. Basoglu (Izmir, Turkey), J. Verbraecken (Edegem (Antwerp), Belgium)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
The investigation of Isovolumic Acceleration (IVA) as a subclinical marker to assess Right Ventricular (RV) function following the application of CPAP for newly diagnosed Obstructive Sleep Apnoea
P. Coss (Dublin , Ireland), G. King (Dublin , Ireland), C. Daly (Dublin , Ireland), R. Murphy (Dublin , Ireland), A. Mc Laughlin (Dublin , Ireland)
|   |
Positive airway pressure emergent Cheyne-Stokes breathing
N. Skjodt (Lethbridge (AB), Canada), R. Platt (Calgary (AB), Canada)
| |
Evaluation quality of life, anxiety, and depression in patients with obstructive sleep syndrome before and after three and twelve months of continuous positive airway pressure therapy
O. Kotsiou (Larissa, Greece), D. Siachpazidou (Larissa, Greece), S. Vasileios (Larissa, Greece), G. Vavougios (Larissa, Greece), Z. Daniil (Larissa, Greece), E. Gogou (Larissa, Greece), C. Pastaka (Larissa, Greece), N. Economou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece)
| |
Health Outcomes of Continuous Positive Airway Pressure versus Mandibular Advancement Device for the Treatment of Severe Obstructive Sleep Apnea: an Individual Participant Data Meta-analysis
W. Trzepizur (Angers, France), P. Cistulli (Sydney, Australia), M. Glos (Berlin, Germany), B. Vielle (Angers, France), K. Sutherland (Sydney, Australia), P. Wijkstra (Groningen, Netherlands), A. Hoekema (Amsterdam, Netherlands), F. Gagnadoux (Angers, France)
| |
Efficacy testing for oral appliance therapy in obstructive sleep apnea
K. Johnson (Rochester, United States of America), M. Herberts (Rochester, United States of America), S. Giri (Rochester, United States of America), P. Escalante (Rochester, United States of America)
| |
Mandibular advancement splints and glucose levels in patients with type 2 diabetes and obstructive sleep apnea: A pilot study
R. Alam (Montréal, Canada), E. Santini (Montréal, Canada), G. Tremblay (Montréal, Canada), J. Kimoff (Montréal, Canada), M. Sherman (Montréal, Canada), F. Almeida (Vancouver, Canada), J. Arcache (Montréal, Canada), A. Benedetti (Montréal, Canada), Z. Negeri (Montréal, Canada), K. Dasgupta (Montréal, Canada), N. Huynh (Montréal, Canada), S. Pamidi (Montréal, Canada)
| |
A novel machine learning approach to predict oral appliance (OA) therapy responses in obstructive sleep apnoea (OSA)
R. Dutta (Hobart, Australia), B. Tong (Randwick, Australia), D. Eckert (Bedford Park, Australia)
| |
Effects of physical exercise on the respiratory muscles, aerobic capacity and quality of life in patients with obstructive sleep apnea
J. Rivera Motta (Cali, Colombia), R. Mosquera (Cali, Colombia), L. Orozco Mejía (Cali, Colombia)
| |
Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP.
Y. Dauvilliers (Montpellier, France), J. Verbraecken (ANtwerp, Belgium), M. Partinen (Helsinki, Finland), J. Hedner (Göteborg, Sweden), T. Saaresranta (Turku, Finland), O. Georgiev (Sofia, Bulgaria), R. Tiholov (Kozloduy, Bulgaria), C. Caussé (Paris, France), I. Lecomte (Paris, France), R. Tamisier (Grenoble, France), P. Lévy (Grenoble, France), J. Lecomte (Paris, France), J. Schwartz (Paris, France), J. Pépin (Grenoble, France)
| |
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
C. CAUSSE (Paris, France), J. Pépin (Grenoble, France), Y. Dauvilliers (MontpellierGrenoble, France), V. Attali (Paris, France), P. Lehert (Mons, Belgium)
| |
Reduced hypoxic burden following carbonic anhydrase inhibition in obstructive sleep apnea – a randomized placebo-controlled study
C. Strassberger (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), K. Stenlöf (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden), D. Zou (Gothenburg, Sweden)
| |
Effect of acetazolamide on visuomotor performance at altitude in healthy people older than 40 years: RCT
A. Reiser (Zurich, Switzerland), M. Furian (Zurich, Switzerland), A. Buergin (Zurich, Switzerland), L. Mayer (Zurich, Switzerland), M. Lichtblau (Zurich, Switzerland), S. Schneider (Zurich, Switzerland), P. Bader (Zurich, Switzerland), P. Appenzeller (Zurich, Switzerland), L. Muralt (Zurich, Switzerland), M. Mademilov (Bishkek, Kyrgyzstan), S. Aydaralieva (Bishkek, Kyrgyzstan), A. Abdraeva (Bishkek, Kyrgyzstan), A. Muratbekova (Bishkek, Kyrgyzstan), T. Sooronbaev (Bishkek, Kyrgyzstan), S. Ulrich (Zurich, Switzerland), K. Bloch (Zurich, Switzerland)
| |
Acetazolamide for Preventing Acute Mountain Sickness in Healthy Older than 40 years. RCT.
M. Furian (Zurich, Switzerland), M. Mademilov (Bishkek, Kyrgyzstan), A. Abdraeva (Bishkek, Kyrgyzstan), M. Lichtblau (Zurich, Switzerland), U. Sheraliev (Bishkek, Kyrgyzstan), N. Marazhapov (Bishkek, Kyrgyzstan), A. Buergin (Zurich, Switzerland), K. Bitos (Zurich, Switzerland), L. Mayer (Zurich, Switzerland), A. Reiser (Zurich, Switzerland), S. Schneider (Zurich, Switzerland), S. Buenzli (Zurich, Switzerland), S. Aydaralieva (Bishkek, Kyrgyzstan), A. Muratbekova (Bishkek, Kyrgyzstan), T. Sooronbaev (Bishkek, Kyrgyzstan), S. Ulrich (Zurich, Switzerland), K. Bloch (Zurich, Switzerland)
| |
Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity
E. Perger (Milano, Italy), P. Castiglioni (Milano, Italy), D. Rosa (Milano, Italy), S. Vicini (Milano, Italy), P. Meriggi (Milano, Italy), A. Faini (Milano, Italy), L. Pini (Brescia, Italy), L. Taranto Montemurro (Boston, United States of America), C. Lombardi (Milano, Italy), G. Parati (Milano, Italy)
| |
Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients
A. Pataka (Thessaloniki, Greece), C. Frantzidis (Thessaloniki, Greece), P. Gkivogkli (Thessaloniki, Greece), C. Nday (Thessaloniki, Greece), P. Chriskos (Thessaloniki, Greece), M. Karagianni (Thessaloniki, Greece), H. Styliadis (Thessaloniki, Greece), E. Paraskevopoulos (Nicosia, Cyprus), C. Kourtidou-Papadeli (Thessaloniki, Greece), P. Bamidis (Thessaloniki, Greece)
| |
Obstructive sleep apnoe improves on Dupilumab in patients treated for polyposis and severe asthma
K. Bergmann (Berlin, Germany), T. Zuberbier (Berlin, Germany)
| |
Inmediate effect and daily use of a vibrating forehead device in patients with positional apnea.
L. Hidalgo Armas (Vitoria, Spain), S. Inglés (Vitoria, Spain), R. Vaca (Madrid, Spain), J. Cordero-Guevara (Vitoria, Spain), J. Durán-Carro (Vitoria, Spain), J. Ullate (Vitoria, Spain), A. Faucher (Barcelona, Spain), J. Rigau (Barcelona, Spain), F. Barbe (Barcelona, Spain), J. Durán-Cantolla (Vitoria, Spain)
| |
Therapy compliance and patient satisfaction of a new vibrating forehead device for positional apnea.
L. Hidalgo Armas (VioriaSanturdejo, Spain), S. Ingles (vitoria, Spain), R. Vaca (Madrid, Spain), J. Cordero-Guevara (Vitoria, Spain), J. Durán-Carro (Vitoria, Spain), J. Ullate (Vitoria, Spain), A. Faucher (Barcelona, Spain), J. Rigau (Barcelona, Spain), F. Barbe (Lleida, Spain), J. Durán-Cantolla (Vitoria, Spain)
| |
The influence of surgical hyoid bone repositioning on upper airway collapsibility
C. Samaha (Beirut, Lebanon), H. Tannous (Beirut, Lebanon), D. Salman (Beirut, Lebanon), J. Ghafari (Beirut, Lebanon), J. Amatoury (Beirut, Lebanon), C. Samaha (Beirut, Lebanon)
| |
Late Breaking Abstract - An assessment of medical utilization across procedure codes in patients with sleep apnea and type 2 diabetes
C. Kaszycki (Pittsburgh, United States of America), Q. Gu (Cambridge, United States of America), F. Huang (Cambridge, United States of America), F. Lam (Toronto, Canada)
| |